AU2020320115A1 - Nitenin analogue compounds and their use in the treatment of chronic and acute pain - Google Patents
Nitenin analogue compounds and their use in the treatment of chronic and acute pain Download PDFInfo
- Publication number
- AU2020320115A1 AU2020320115A1 AU2020320115A AU2020320115A AU2020320115A1 AU 2020320115 A1 AU2020320115 A1 AU 2020320115A1 AU 2020320115 A AU2020320115 A AU 2020320115A AU 2020320115 A AU2020320115 A AU 2020320115A AU 2020320115 A1 AU2020320115 A1 AU 2020320115A1
- Authority
- AU
- Australia
- Prior art keywords
- pain
- alkyl
- formula
- compound
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/36—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT11568519 | 2019-07-31 | ||
| PT115685 | 2019-07-31 | ||
| PCT/IB2020/056915 WO2021019373A1 (en) | 2019-07-31 | 2020-07-22 | Nitenin analogue compounds and their use in the treatment of chronic and acute pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2020320115A1 true AU2020320115A1 (en) | 2022-02-24 |
Family
ID=72240450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020320115A Pending AU2020320115A1 (en) | 2019-07-31 | 2020-07-22 | Nitenin analogue compounds and their use in the treatment of chronic and acute pain |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12336977B2 (https=) |
| EP (1) | EP4003984A1 (https=) |
| JP (1) | JP2022544057A (https=) |
| CN (1) | CN114616230A (https=) |
| AU (1) | AU2020320115A1 (https=) |
| CA (1) | CA3149175A1 (https=) |
| IL (1) | IL290192A (https=) |
| MX (1) | MX2022001186A (https=) |
| WO (1) | WO2021019373A1 (https=) |
| ZA (1) | ZA202201154B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4003984A1 (en) | 2019-07-31 | 2022-06-01 | Sea4Us - Biotecnologia e Recursos Marinhos, Lda. | Nitenin analogue compounds and their use in the treatment of chronic and acute pain |
| CN116115739B (zh) * | 2022-12-29 | 2024-01-09 | 天津市肿瘤医院（天津医科大学肿瘤医院） | 胃动素及其受体激动剂的应用 |
| WO2026013449A2 (en) * | 2024-07-11 | 2026-01-15 | Sea4Us - Biotecnologia E Recursos Marinhos, Sa | Oxazolidone-derived compounds and their use in the treatment of chronic and acute pain |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7375136B2 (en) | 2001-03-08 | 2008-05-20 | Emory University | pH-dependent NMDA receptor antagonists |
| GB0305149D0 (en) * | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Compounds for the treatment of pain |
| WO2007009462A2 (en) | 2005-07-15 | 2007-01-25 | Region Hovedstaden V/Glostrup Hospital | Treatment of migraine and headaches |
| ES2345527B1 (es) | 2008-10-08 | 2011-09-08 | Hospital Clinic I Provincial De Barcelona | Sustancias bloqueadoras de los canales kv 1.3 para el tratamiento de enfermedades asociadas a hiperplasia de la intima. |
| KR101939401B1 (ko) | 2011-11-10 | 2019-01-16 | 가천대학교 산학협력단 | 단핵식세포계 세포의 ａｇｅ-알부민 합성 또는 분비 저해제를 유효성분으로 포함하는 허혈성 심장질환 예방 또는 치료용 조성물 |
| CN106537149A (zh) * | 2014-04-01 | 2017-03-22 | 宝洁公司 | 用于筛选色氨酸通道的方法 |
| DK3126330T3 (en) | 2014-04-04 | 2019-04-23 | Pfizer | BICYCLE-FUSED HETEROARYL OR ARYL COMPOUNDS AND USE THEREOF AS IRAC4 INHIBITORS |
| CN106146530A (zh) * | 2015-04-14 | 2016-11-23 | 中国科学院生态环境研究中心 | 一种合成cephalosporolides E,F,H,I的新方法 |
| EP4003984A1 (en) | 2019-07-31 | 2022-06-01 | Sea4Us - Biotecnologia e Recursos Marinhos, Lda. | Nitenin analogue compounds and their use in the treatment of chronic and acute pain |
-
2020
- 2020-07-22 EP EP20761628.5A patent/EP4003984A1/en active Pending
- 2020-07-22 CN CN202080057704.6A patent/CN114616230A/zh active Pending
- 2020-07-22 JP JP2022506029A patent/JP2022544057A/ja active Pending
- 2020-07-22 CA CA3149175A patent/CA3149175A1/en active Pending
- 2020-07-22 AU AU2020320115A patent/AU2020320115A1/en active Pending
- 2020-07-22 MX MX2022001186A patent/MX2022001186A/es unknown
- 2020-07-22 WO PCT/IB2020/056915 patent/WO2021019373A1/en not_active Ceased
- 2020-07-22 US US17/631,135 patent/US12336977B2/en active Active
-
2022
- 2022-01-25 ZA ZA2022/01154A patent/ZA202201154B/en unknown
- 2022-01-27 IL IL290192A patent/IL290192A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3149175A1 (en) | 2021-02-04 |
| ZA202201154B (en) | 2024-02-28 |
| IL290192A (en) | 2022-03-01 |
| CN114616230A (zh) | 2022-06-10 |
| WO2021019373A4 (en) | 2021-03-25 |
| US12336977B2 (en) | 2025-06-24 |
| MX2022001186A (es) | 2022-05-11 |
| JP2022544057A (ja) | 2022-10-17 |
| WO2021019373A1 (en) | 2021-02-04 |
| EP4003984A1 (en) | 2022-06-01 |
| US20220288017A1 (en) | 2022-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12336977B2 (en) | Nitenin analogue compounds and their use in the treatment of chronic and acute pain | |
| KR101335941B1 (ko) | 수면-각성 장애의 치료 | |
| JP2025163030A (ja) | 慢性および急性疼痛の治療における使用のためのｋｖ１．３アンタゴニスト | |
| Mattioli et al. | Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P1–11 | |
| Sheard | Clinical pharmacology of aggressive behavior | |
| Strumper et al. | Antidepressants as long-acting local anesthetics | |
| EP1919477B1 (en) | Use of [2-(2-methylimidazol-1-yl)methyl]pyridine for treating sleep disorders | |
| EP3556366A1 (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| JP5223859B2 (ja) | 神経因性疼痛新規予防剤及び／又は治療剤 | |
| AU2020322218B2 (en) | Kv1.3 antagonists for use in the treatment of chronic and acute pain | |
| HK40076622A (en) | Nitenin analogue compounds and their use in the treatment of chronic and acute pain | |
| US20050234063A1 (en) | Therapeutic agent for brain hemorrhage | |
| Al‑Kaleel et al. | The effect of Madopar on absence‑like seizures in WAG/Rij rats | |
| JP2020059746A (ja) | ハロアルキルアミンを用いた神経細胞死の低減方法 | |
| JP6447496B2 (ja) | 多発性硬化症の治療剤又は予防剤 | |
| US7834040B2 (en) | Isoxazolic derivative to relieve neuropathic pain | |
| MXPA02006374A (es) | Combinacion de trimebutina con un opioide analgesico. | |
| Huotarinen | Deep Brain Stimulation of the Subthalamic Nucleus, Effect on Parkinsonian Motor Symptoms and Experimental Effects with CDNF | |
| GARCIA et al. | Animal models of REM dysfunctions: what they tell us about the cause of narcolepsy and RBD? | |
| HK1117402B (en) | Use of [2-(2-methylimidazol-1-yl)methyl]pyridine for treating sleep disorders | |
| KR20030006576A (ko) | 라이소포스파티딘산을 포함하는 뇌졸중 예방 및 치료용조성물 |